,
volume 202
,
issue 12
,
pages 1656-1665
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study
Thomas M. Drake
1
,
Jennifer K. Quint
2
,
Huzaifa Adamali
3, 4
,
Sarah Agnew
5
,
Suresh Babu
6
,
Christopher M. Barber
7
,
Shaney Barratt
3, 4
,
Elisabeth Bendstrup
8
,
Stephen Bianchi
7
,
Diego Castillo Villegas
9
,
Nazia Chaudhuri
10, 11
,
Felix Chua
12
,
Robina Coker
13
,
WILLIAM CHANG
14
,
Anjali Crawshaw
15
,
Louise E. Crowley
16
,
Davinder Dosanjh
15
,
Christine A. Fiddler
17
,
IAN A. FORREST
18
,
Peter M George
2, 12
,
Michael A. Gibbons
19
,
Katherine Groom
13
,
Sarah Haney
20
,
Simon P. Hart
21
,
Emily Heiden
22
,
Michael Henry
23
,
Ling-Pei Ho
24
,
Rachel K. Hoyles
24
,
John Hutchinson
25
,
Killian Hurley
26, 27
,
Mark Jones
22, 28
,
Steve Jones
29
,
Maria Kokosi
12, 30
,
Michael Kreuter
31
,
Laura S. MacKay
20
,
Siva Mahendran
32
,
George Margaritopoulos
10
,
Maria Molina-Molina
33
,
Philip L. Molyneaux
2
,
Aiden O'Brien
34
,
Katherine O’Reilly
35
,
Alice Packham
15
,
Helen Parfrey
17
,
Venerino Poletti
8, 36
,
Joanna C. Porter
37
,
Elisabetta Renzoni
12
,
Pilar Rivera-Ortega
10
,
Anne-Marie Russell
2, 38
,
Gauri Saini
14
,
Lisa G. Spencer
5
,
Giulia M. Stella
39
,
Helen Stone
40
,
Sharon Sturney
41
,
David R. Thickett
15, 16
,
Muhunthan Thillai
17
,
Tim Wallis
22, 28
,
Katie Ward
2
,
Athol U. Wells
12
,
Alex West
30
,
Melissa Wickremasinghe
38
,
Felix Woodhead
42
,
Glenn Hearson
43
,
Lucy Howard
43
,
J. BAILLIE
44, 45
,
Iain Stewart
43
,
R. Gisli Jenkins
14, 43
3
Bristol Interstitial Lung Disease Service, North Bristol NHS Trust and
6
Queen Alexandra Hospital, Portsmouth, United Kingdom
|
7
Northern General Hospital, Sheffield, United Kingdom
|
12
Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom
|
17
Cambridge Interstitial Lung Disease Service, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UNITED KINGDOM
|
18
Department of Respiratory Medicine, Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
|
19
South West Peninsula ILD Network, Royal Devon & Exeter Foundation NHS Trust, Exeter, United Kingdom
|
20
Northumbria Specialist Emergency Care Hospital, Northumbria Healthcare NHS Foundation Trust, Cramlington, United Kingdom
|
21
Respiratory Research Group, Hull York Medical School, Castle Hill Hospital, Cottingham, United Kingdom
|
25
King’s Mill Hospital, Nottinghamshire, United Kingdom
|
28
29
Action for Pulmonary Fibrosis, Stuart House, Peterborough, United Kingdom
|
30
Guys and St. Thomas’ NHS Trust, London, United Kingdom
|
31
32
Kingston Hospital NHS Foundation Trust, Surrey, United Kingdom
|
33
35
Department of Respiratory Medicine, Mater Misericordiae University Hospital, Dublin, Ireland
|
36
Department of Diseases of the Thorax, Morgagni Hospital, Forli, Italy
|
39
Laboratory of Biochemistry and Genetics, Pneumology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy
|
40
University Hospital North Midlands NHS Trust, Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom
|
41
Royal United Hospitals Bath NHS Foundation Trust, Bath, United Kingdom
|
42
Institute of Lung Health, Interstitial Lung Disease Unit, Glenfield Hospital, Leicester, United Kingdom
|
45
Intensive Care Unit, Royal Infirmary Edinburgh, Edinburgh, United Kingdom
|
Publication type: Journal Article
Publication date: 2020-10-02
scimago Q1
wos Q1
SJR: 5.076
CiteScore: 23.8
Impact factor: 19.4
ISSN: 1073449X, 15354970
PubMed ID:
33007173
Critical Care and Intensive Care Medicine
Pulmonary and Respiratory Medicine
Abstract
Rationale: The impact of coronavirus disease (COVID-19) on patients with interstitial lung disease (ILD) has not been established.Objectives: To assess outcomes in patients with ILD hospitalized for COVID-19 versus those without ILD in a contemporaneous age-, sex-, and comorbidity-matched population.Methods: An international multicenter audit of patients with a prior diagnosis of ILD admitted to the hospital with COVID-19 between March 1 and May 1, 2020, was undertaken and compared with patients without ILD, obtained from the ISARIC4C (International Severe Acute Respiratory and Emerging Infection Consortium Coronavirus Clinical Characterisation Consortium) cohort, admitted with COVID-19 over the same period. The primary outcome was survival. Secondary analysis distinguished idiopathic pulmonary fibrosis from non-idiopathic pulmonary fibrosis ILD and used lung function to determine the greatest risks of death.Measurements and Main Results: Data from 349 patients with ILD across Europe were included, of whom 161 were admitted to the hospital with laboratory or clinical evidence of COVID-19 and eligible for propensity score matching. Overall mortality was 49% (79/161) in patients with ILD with COVID-19. After matching, patients with ILD with COVID-19 had significantly poorer survival (hazard ratio [HR], 1.60; confidence interval, 1.17-2.18; P = 0.003) than age-, sex-, and comorbidity-matched controls without ILD. Patients with an FVC of <80% had an increased risk of death versus patients with FVC ≥80% (HR, 1.72; 1.05-2.83). Furthermore, obese patients with ILD had an elevated risk of death (HR, 2.27; 1.39-3.71).Conclusions: Patients with ILD are at increased risk of death from COVID-19, particularly those with poor lung function and obesity. Stringent precautions should be taken to avoid COVID-19 in patients with ILD.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
6
7
|
|
|
American Journal of Respiratory and Critical Care Medicine
7 publications, 3.85%
|
|
|
European Respiratory Journal
7 publications, 3.85%
|
|
|
Annals of the American Thoracic Society
6 publications, 3.3%
|
|
|
Respirology
5 publications, 2.75%
|
|
|
Journal of Clinical Medicine
4 publications, 2.2%
|
|
|
Frontiers in Immunology
4 publications, 2.2%
|
|
|
BMC Pulmonary Medicine
4 publications, 2.2%
|
|
|
Chest
4 publications, 2.2%
|
|
|
Respiratory Investigation
4 publications, 2.2%
|
|
|
Cureus
4 publications, 2.2%
|
|
|
ERJ Open Research
3 publications, 1.65%
|
|
|
Radiology
3 publications, 1.65%
|
|
|
Current Opinion in Pulmonary Medicine
3 publications, 1.65%
|
|
|
Journal of Personalized Medicine
3 publications, 1.65%
|
|
|
Frontiers in Medicine
3 publications, 1.65%
|
|
|
Respiratory Medicine and Research
3 publications, 1.65%
|
|
|
International Immunopharmacology
3 publications, 1.65%
|
|
|
The Lancet Respiratory Medicine
3 publications, 1.65%
|
|
|
Pneumologie
3 publications, 1.65%
|
|
|
BMJ Open Respiratory Research
3 publications, 1.65%
|
|
|
Breathe
2 publications, 1.1%
|
|
|
International Journal of Molecular Sciences
2 publications, 1.1%
|
|
|
Transplantology
2 publications, 1.1%
|
|
|
Frontiers in Pharmacology
2 publications, 1.1%
|
|
|
Respiratory Research
2 publications, 1.1%
|
|
|
Respiratory Medicine
2 publications, 1.1%
|
|
|
Respiratory Medicine Case Reports
2 publications, 1.1%
|
|
|
Journal of Infection and Chemotherapy
2 publications, 1.1%
|
|
|
Archivos de Bronconeumologia
2 publications, 1.1%
|
|
|
1
2
3
4
5
6
7
|
Publishers
|
5
10
15
20
25
30
35
40
45
50
|
|
|
Elsevier
46 publications, 25.27%
|
|
|
MDPI
18 publications, 9.89%
|
|
|
Springer Nature
18 publications, 9.89%
|
|
|
American Thoracic Society
13 publications, 7.14%
|
|
|
European Respiratory Society (ERS)
13 publications, 7.14%
|
|
|
Frontiers Media S.A.
12 publications, 6.59%
|
|
|
Wiley
9 publications, 4.95%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
7 publications, 3.85%
|
|
|
Taylor & Francis
6 publications, 3.3%
|
|
|
Cold Spring Harbor Laboratory
6 publications, 3.3%
|
|
|
BMJ
5 publications, 2.75%
|
|
|
Radiological Society of North America (RSNA)
3 publications, 1.65%
|
|
|
Georg Thieme Verlag KG
3 publications, 1.65%
|
|
|
SAGE
2 publications, 1.1%
|
|
|
Public Library of Science (PLoS)
2 publications, 1.1%
|
|
|
AME Publishing Company
2 publications, 1.1%
|
|
|
JMIR Publications
1 publication, 0.55%
|
|
|
Microbiology Society
1 publication, 0.55%
|
|
|
American Society for Microbiology
1 publication, 0.55%
|
|
|
National Center for Global Health and Medicine (JST)
1 publication, 0.55%
|
|
|
Annual Reviews
1 publication, 0.55%
|
|
|
Scientific and Practical Reviewed Journal Pulmonology
1 publication, 0.55%
|
|
|
LLC "Medical Knowledge and Technologies"
1 publication, 0.55%
|
|
|
Oxford University Press
1 publication, 0.55%
|
|
|
Research Square Platform LLC
1 publication, 0.55%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 0.55%
|
|
|
PAGEPress Publications
1 publication, 0.55%
|
|
|
Apex Publishing
1 publication, 0.55%
|
|
|
5
10
15
20
25
30
35
40
45
50
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
182
Total citations:
182
Citations from 2024:
34
(18.68%)
The most citing journal
Citations in journal:
7
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Drake T. M. et al. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study // American Journal of Respiratory and Critical Care Medicine. 2020. Vol. 202. No. 12. pp. 1656-1665.
GOST all authors (up to 50)
Copy
Drake T. M. et al. Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study // American Journal of Respiratory and Critical Care Medicine. 2020. Vol. 202. No. 12. pp. 1656-1665.
Cite this
RIS
Cite this
BibTex (up to 50 authors)
Copy
@article{2020_Drake,
author = {Thomas M. Drake and Jennifer K. Quint and Huzaifa Adamali and Sarah Agnew and Suresh Babu and Christopher M. Barber and Shaney Barratt and Elisabeth Bendstrup and Stephen Bianchi and Diego Castillo Villegas and Nazia Chaudhuri and Felix Chua and Robina Coker and WILLIAM CHANG and Anjali Crawshaw and Louise E. Crowley and Davinder Dosanjh and Christine A. Fiddler and IAN A. FORREST and Peter M George and Michael A. Gibbons and Katherine Groom and Sarah Haney and Simon P. Hart and Emily Heiden and Michael Henry and Ling-Pei Ho and Rachel K. Hoyles and John Hutchinson and Killian Hurley and Mark Jones and Steve Jones and Maria Kokosi and Michael Kreuter and Laura S. MacKay and Siva Mahendran and George Margaritopoulos and Maria Molina-Molina and Philip L. Molyneaux and Aiden O'Brien and Katherine O’Reilly and Alice Packham and Helen Parfrey and Venerino Poletti and Joanna C. Porter and Elisabetta Renzoni and Pilar Rivera-Ortega and Anne-Marie Russell and Gauri Saini and Lisa G. Spencer and others},
title = {Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study},
journal = {American Journal of Respiratory and Critical Care Medicine},
year = {2020},
volume = {202},
publisher = {American Thoracic Society},
month = {oct},
url = {https://doi.org/10.1164/rccm.202007-2794OC},
number = {12},
pages = {1656--1665},
doi = {10.1164/rccm.202007-2794OC}
}
Cite this
MLA
Copy
Drake, Thomas M., et al. “Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study.” American Journal of Respiratory and Critical Care Medicine, vol. 202, no. 12, Oct. 2020, pp. 1656-1665. https://doi.org/10.1164/rccm.202007-2794OC.